Adimmune Develop Combo Flu-COVID 19 Vaccine

Reporter/Provider - Alex Chen, Ken Ning

class="meta mb-0">Publish Date - 2021-09-15T11:44:38Z228 views

Indonesia’s National Agency of Drug and Food Control has approved Adimmune Corporation’s application for a Phase 2 clinical trial. The Taiwanese vaccine producer says it is developing a combination vaccine for flu and Covid-19. Experts say while more data is needed, the combination shows promise. Ken Ning has more.

We value your privacy.

We use cookies to analyze the traffic of TaiwanPlus to improve our service. Click here to find out more about TaiwanPlus's privacy policy.

Learn more Got it

Like what you see?

Download TaiwanPlus App now!

Download